^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SNC109

i
Other names: SNC109, SNC 109, SNC-109
Associations
Trials
Company:
Shanghai Simnova Bio
Drug class:
HER2-targeted CAR-T immunotherapy, EGFR-targeted CAR-T immunotherapy, EGFRvIII-targeted CAR-T immunotherapy, IL-13Rα2-targeted CAR-T immunotherapy
Associations
Trials